SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-071950
Filing Date
2011-08-03
Accepted
2011-08-03 08:30:33
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b86736e10vq.htm 10-Q 543111
2 EX-12 b86736exv12.htm EX-12 18329
3 EX-31.1 b86736exv31w1.htm EX-31.1 8469
4 EX-31.2 b86736exv31w2.htm EX-31.2 8465
5 EX-32.1 b86736exv32w1.htm EX-32.1 3511
6 EX-32.2 b86736exv32w2.htm EX-32.2 3554
  Complete submission text file 0000950123-11-071950.txt   1868118

Data Files

Seq Description Document Type Size
7 EX-101 INSTANCE DOCUMENT alny-20110630.xml EX-101.INS 202523
8 EX-101 SCHEMA DOCUMENT alny-20110630.xsd EX-101.SCH 7944
9 EX-101 CALCULATION LINKBASE DOCUMENT alny-20110630_cal.xml EX-101.CAL 32495
10 EX-101 LABELS LINKBASE DOCUMENT alny-20110630_lab.xml EX-101.LAB 100494
11 EX-101 PRESENTATION LINKBASE DOCUMENT alny-20110630_pre.xml EX-101.PRE 64413
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 111005372
SIC: 2834 Pharmaceutical Preparations